Chemopreventive effect of nonsteroidal anti-inflammatory drugs on 9,10-dimethylbenz[a]anthracene-induced lung carcinogenesis in mice

Oncology Research

Volumn 17, Issue 11-12, 2009, Pages 505-518

  Saini, R K ^a   Sanyal, S N ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

9,10 Dimethylbenz a anthracene; Mice lung tumorigenesis; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ACID PHOSPHATASE; ALKALINE PHOSPHATASE; CATALASE; CELECOXIB; CYTOCHROME B5; CYTOCHROME P450; DIMETHYLBENZ[A]ANTHRACENE; ETORICOXIB; GLUCOSE 6 PHOSPHATASE; GLUTATHIONE TRANSFERASE; LACTATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; SUPEROXIDE DISMUTASE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID; PTGS2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; DRUG STRUCTURE; HISTOPATHOLOGY; LIPID COMPOSITION; LIPID PEROXIDATION; LIVER CARCINOGENESIS; LUNG ADENOMA; LUNG ALVEOLUS MACROPHAGE; LUNG CARCINOGENESIS; LYMPHOCYTE COUNT; MALE; MOUSE; NEUTROPHIL COUNT; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; TUMOR VOLUME; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CYCLOOXYGENASE 2; LIPID PEROXIDATION; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; PHOSPHOLIPIDS;

EID: 70350474283     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009789745520     Document Type: Article

References (72)

1. Jemal, A.; Tiwari, R. C.; Murray, T.; Ghafoor, A.; Samuels, A.; Ward, E.; Feuer, E. J.; Thun, M. Cancer statistics. CA Cancer J. Clin. 54(1):8-29; 2004.
2. Umemura, T.; Kodama, Y.; Nishikawa, A.; Hioki, K.; Nowura, T.; Kauki, K.; Kuroiwa, T.; Ishii, Y.; Kurokawa, Y.; Hirose, M. Nine week detection of six genotoxic lung carcinogens using the ras H2/BHT mouse model. Cancer Lett. 231:314-318; 2006.
3. Malkinsion, A. M. Primary lung tumors in mice as an aid for understanding, prevention and treating human adenocarcinoma of the lung. Lung Cancer 32:265-279; 2001.
4. Guengrich, F. P.; Shimada, T. Activation of procarcinogen by human cytochrome p450 enzymes. Mutat. Res. 400: 201-213; 1998.
5. Tockman, M. S.; Anthonison, M. R.; Wright, E. C.; Donithan, M. G. Airways obstruction and the risk for lung cancer. Ann. Intern. Med. 106:512-518; 1987.
6. Tsutsumi, M.; Kitada, H.; Shiraiwa, K.; Takahama, M.; Tsujiuchi, T.; Sakitani, H.; Sasaki, Y.; Murakawa, K.; Yoshimoto, M.; Konishi, Y. Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats. Carcinogenesis 21: 251-256; 2000.
7. 2 production is not sufficient for lung tumorigenesis in mice. Carcinogenesis 26:209-217; 2004.
8. Bauer, A. K.; Dwyer-Nield, L. D.; Malkinson, A. M. High cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) contents in mouse lung tumors. Carcinogenesis 21: 543-550; 2000.
9. DeWitt, D. L.; Meade, E. A.; Smith, W. L. PGH synthase isoenzyme selectivity: The potential for safer nonsteroidal antiinflammatory drugs. Am. J. Med. 95(2A):40S-44S; 1993.
10. Kujubu, D. A.; Fletcher, B. S.; Varnum, B. C.; Lim, R. W.; Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem. 20:12866-12872; 1991.
11. Kutchera, W.; Jones, D. A.; Matsunami, N.; Groden, J.; McIntyre, T. M.; Zimmerman, G. A.; White, R. L.; Prescott, S. M. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: Evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA 93:4816-4820; 1996.
12. Eberhart, C. E.; Coffey, R. J.; Radhika, A.; Giardiello, F. M.; Ferrenbach, S.; DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183-1188; 1994.
13. Kundu, N.; Yang, Q.; Dorsey, R.; Fulton, A. M. Increased cycloxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer. Int. J. Cancer 93: 681-686; 2001.
14. Wolff, H.; Saukkonen, K.; Anttila, S.; Karjalainen, A.; Vainio, H.; Ristimäki, A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58:4997-5001; 1998.
15. Hida, T.; Yatabe, Y.; Achiwa, H.; Muramatsu, H.; Kozaki, Ki.; Nakamura, S.; Ogawa, M.; Mitsudomi, T.; Sugiura, T.; Takahashi, T. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 58:1761-3764; 1998.
16. Ermert, L.; Dierkes, C.; Ermert, M. Immunohistochemical expression of cyclooxygenase isoenzymes and down-stream enzymes in human lung tumors. Clin. Cancer Res. 9:1604-1610; 2003.
17. Liu, C. H.; Chang, S. H.; Narko, K.; Trifan, O. C.; Wu, M. T.; Smith, E.; Haudenschild, C.; Lane, T. F.; Hla, T. Overexpression of cycloxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem. 276(21): 18563-18569; 2001.
18. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276(21):18075-18081; 2001.
19. Munkarah, A. R.; Morris, R.; Baumann, P.; Deppe, G.; Malone, J.; Diamond, M. P.; Saed, G. M. Effects of prostaglandin E2 on proliferation and apoptosis of epithelial ovarian cancer cells. J. Soc. Gynecol. Invest. 6:168-173; 2002.
20. Tsujii, M.; DuBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 3:493-501; 1995.
21. 2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc. Natl. Acad. Sci. USA 101(2):591-596; 2004.
22. Young, M. R. I. Eicosanoids and the immunology of cancer. Cancer Metastasis Rev. 13:337-348; 1994.
23. Mutoh, M.; Watanabe, K.; Kitamura, T.; Shoji, Y.; Takahashi, M.; Kawamori, T.; Tani, K.; Kobayashi, M.; Maruyama, T.; Kobayashi, K.; Ohuchida, S.; Sugimoto, Y.; Narumiya, S.; Sugimura, T.; Wakabayashi, K. Involvement of prostaglandin E receptor subtype EP4 in colon carcinogenesis. Cancer Res. 62:28-32; 2002.
24. 2 by oncogenic Ras in human non-small cell lung cancer. J. Biol. Chem. 272(23): 14501-14504; 1997.
25. Hida, T.; Leytan, J.; Makhija, A. N.; Ben, A. V.; Hla, T.; Martines, A.; Mulshine, J.; Malkani, S.; Chung, P.; Moody, T. W. Non-small cell lung cancer cyclooxygenase activity and progression are inhibited by non-steroidal anti-inflammatory drugs. Anticancer Res. 18:775-782; 1998.
26. Schreinemachers, D. M.; Everson, R. B. Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5(2):138-146; 1994.
27. Thun, M. J. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metastasis Rev. 13(3-4):269-277; 1994.
28. Dubois, R. N.; Giardiello, F. M.; Smalley, W. E. Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention. Gastroenterol. Clin. North Am. 25(87):773-791; 1996.
29. Oshima, M.; Dinchuk, J. E.; Kargman, S. L.; Oshima, H.; Hancock, B.; Kwong, E.; Trzaskos, J. M.; Evans, J. F.; Taketo, M. M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cycloxygenase 2 (COX-2). Cell 87(5):803-809; 1996.
30. Kawamori, T.; Rao, C. V.; Seibert, K.; Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res. 58(3):409-412; 1998.
31. Egan, K. M.; Stampfer, M. J.; Giovannucci, E.; Rosner, B. A.; Colditz, G. A. Prospective study of regular aspirin use and the risk of breast cancer. J. Natl. Cancer Inst. 88(14):988-993; 1996.
32. Farrow, D. C.; Vaughan, T. L.; Hansten, P. D.; Stanford, J. L.; Risch, H. A.; Gammon, M. D.; Chow, W. H.; Dub-Row, R.; Ahsan, H.; Mayne, S. T.; Schoenberg, J. B.; West, A. B.; Rotterdam, H.; Fraumeni, Jr., J. F.; Blot, W. J. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 7(2):97-102; 1998.
33. Saini, R. K.; Sanyal, S. N. Pulmonary carcinogenesis in mice with a single intratracheal instillation of 9,10-dimethylbenz(a)anthracene. Drug Chem. Toxicol. 31(4): 459-471; 2008.
34. Kanwar, S. S.; Vaiphei, K.; Nehru, B.; Sanyal, S. N. Chemopreventive effect of non-steroidal anti-inflammatory drugs on 1, 2-dimethyle hydrazine induced colon carcinogenesis in rat. Toxicol. Mech. Methods 17:1-8; 2007.
35. Kanwar, S. S.; Vaiphei, K.; Nehru, B.; Sanyal, S. N. Chemopreventive effect of non-steroidal anti-inflammatory drugs in the membrane lipid composition and fluidity parameters of the 1, 2-dimethyl hydrazine induced colon carcinogenesis in rat. Drug Chem. Toxicol. 30:293-300; 2007.
36. Kanwar, S. S.; Vaiphei, K.; Nehru, B.; Sanyal, S. N. Anti-oxidative effects of non-steroidal anti-inflammatory drugs (NSAIDs) during the initiation stage of experimental colon carcinogenesis in rat. J. Env. Pathol. Toxicol. Oncol. 27(2):89-100; 2008.
37. Kawada, H.; Horiuchi, T.; Shannon, J. M.; Kuroki, Y.; Voelker, D. R.; Mason, R. J. Alveolar type II cells, surfactant protein A (SP-A), and the phospholipid components of surfactant in acute silicosis in rat. Am. Rev. Respir. Dis. 140:460-470; 1989.
38. Bauer, A. K.; Dwyer-Nield, L. D.; Hankin, J. A.; Murphy, R. C.; Malkinson, A. M. The lung tumor promoter, butylated hydroxytoluene (BHT), causes chronic inflammation in promotion-sensitive BALB/c BYJ mice but not in promotion-resistant CXB4 mice. Toxicology 169(1): 1-15; 2001.
39. Witschi, H.; Espiritu, I.; Uyeninami, D. Chemoprevention of tobacco smoke-induced lung tumor in A/J strain mice with dilatory myoinositol and dexamethasone. Carcinogenesis 20:1375-1378; 1999.
40. Solem, L. H.; Yesner, R. Histological typing of lung tumors. International histological classification of tumors. Geneva: World Health Organization; 1981.
41. Omura, T.; Sato, R. The carbon monoxide binding pigment of liver. J. Biol. Chem. 239:2370-2378; 1964.
42. Habig, W. H.; Pabst, M. H.; Jokoby, W. B. Glutathione-S-transferases. The first step in mercapturic acid formation J. Biol. Chem. 249:7130-7139; 1974.
43. Lees, M.; Paxman, S. Modification of the Lowry procedure for the analysis of proteolipid protein. Anal. Biochem. 47:184-194; 1972.
44. Bergmeyer, H. U.; Bernt, E., editors. Methods of enzymatic analysis, vol. II. New York: Verlag/Academic Press; 1971:5574-5579.
45. Freedland, R. A.; Harper, A. E. Metabolic adaptations in higher animals. The study of metabolic pathways by means of metabolic adaptations. J. Biol. Chem. 234:1350-1354; 1959.
46. Chen, P. S.; Toribara, T. Y.; Warner, H. Microdetermination of phosphorus. Anal. Chem. 28:1756-1758; 1956.
47. Kun, E.; Abood, L. G. Colorimetric estimation of succinic dehydrogenase by triphenyltetrazolium chloride. Science 109:144-146; 1949.
48. Nair, P.; Kanwar, S. S.; Sanyal, S. N. Effects of non steroidal anti-inflammatory drugs on the antioxidant defense system and the membrane functions in the rat intestine. Nutr. Hosp. 21(6):638-649; 2006.
49. Sanyal, S. N.; Sood, N.; Kaushal, N. Alterations in the lipid profile and membrane dynamics of rat intestinal brush border membrane induced by different classes of nonsteroidal anti-inflammatory drugs. Toxicol. Mech. Methods 17:49-56; 2007.
50. Mittal, N.; Kanwar, S. S.; Sanyal, S. N. Effect of nonsteroidal anti-inflammatory drugs and the procarcinogen 1,2-dimethylhydrazine on the antioxidant defense system. Int. J. Toxicol. 27:169-174; 2008.
51. Burford, C. R.; Lubet, R. A.; Eto, I.; Juliana, M. M.; Kelloff, G. J.; Grubbs, C. J.; Steele, V. E. Effect of reduced body weight gain on the evaluation of chemopreventive agents in the methylnitrosourea-induced mammary cancer model. Carcinogenesis 20(1):71-76; 1999.
52. Peacock, P. M.; Peacock, P. R. Spontaneous and induced hyperplasia and neoplasia in the mouse lung. Br. J. Cancer 20(1):127-133; 1966.
53. Kisley, L. R.; Barrett, B. S.; Dwyer-Nield, L. D.; Bauer, A. K.; Thompson, D. C.; Malkinson, A. M. Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice. Carcinogenesis 23:1653-1660; 2002.
54. Laupeze, B.; Amiot, L.; Sparfel, L.; Ferrec, E. L.; Fauchet, R.; Fardel, O. Polycyclic aromatic hydrocarbons affect functional differentiation and maturation of human monocyte-derived dendritic cells. J. Immunol. 168:2652-2658; 2002.
55. Vaananen, P. M.; Meddings, J. B.; Wallace, J. L. Role of oxygen derived free radicals in indomethacin induced gastric injury. Am. J. Physiol. 26:G470-G475; 1991.
56. Dormandy, T. L. Free-radical oxidation and antioxidants. Lancet 25:647-650; 1978.
57. Yoshikawa, M.; Fukui, K.; Kuriyama, S.; Tsujimoto, T.; Nakatani, Y.; Toyokawa, Y.; Kurematsu, Y.; Awata, J.; Shiroi, A.; Fukui, H.; Tsutsumi, M. Hepatic adenomas treated with percutaneous ethanol injection in a patient with glycogen storage disease type Ia. J. Gastroenterol. 36(1):52-61; 2001.
58. Ukawa, H.; Yamakuni, H.; Kato, S.; Takeuchi, K. Effects of cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal antiinflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig. Dis. Sci. 43(9):2003-2011; 1998.
59. Sánchez, S.; Martín, M. J.; Ortiz, P.; Motilva, V.; de La Lastra, C. A. Effects of dipyrone on inflammatory infiltration and oxidative metabolism in gastric mucosa: Comparison with acetaminophen and diclofenac. Dig. Dis. Sci. 47(6):1389-1398; 2002.
60. Jiménez, D.; Martin, M. J.; Pozo, D.; Alarcón, C.; Esteban, J.; Bruseghini, L.; Esteras, A.; Motilva, V. Mechanisms involved in protection afforded by L-arginine in ibuprofen-induced gastric damage: Role of nitric oxide and prostaglandins. Dig. Dis. Sci. 47(1):44-53; 2002.
61. Villegas, I.; Martín, M. J.; La Casa, C.; Motilva, V.; de La Lastra, C. A. Effects of oxicam inhibitors of cyclooxygenase on oxidative stress generation in rat gastric mucosa. A comparative study. Free Radic. Res. 36(7):769-777; 2002.
62. Carruthers, A.; Melchoir, D. L. Human erythrocyte hexose transporter activity is governed by bilayer lipid composition in reconstituted vesicles. Biochemistry 23:6901-6911; 1984.
63. Matsumoto, T.; Fontaine, O.; Rasmussen, H. Effect of 1,25-dihydroxyvitamin D3 on phospholipid metabolism in chick duodenal mucosal cell. Relationship to its mechanism of action. J. Biol. Chem. 10(7):3354-3360; 1981.
64. Lichtenberger, L. M.; Ulloa, C.; Vanous, A. L.; Romero, J. J.; Dial, E. J.; Illich, P. A.; Walters, E. T. Zwitterionic phospholipids enhance aspirin's therapeutic activity, as demonstrated in rodent model systems. J. Pharmacol. Exp. Ther. 277(3): 1221-1227; 1996.
65. Vander Meer, B. W.; Van Hoeven, R. P.; Van Blitterswijk, W. J. Steady-state fluorescence polarization data in membranes. Resolution into physical parameters by an extended Perrin equation for restricted rotation of fluorophores. Biochim. Biophys. Acta 854:38-44; 1986.
66. Franks, D. H. Oat cell carcinoma of the lung. Ariz. Med. 38(8):646-650; 1976.
67. Lichtenberger, L. M. The hydrophobic barrier properties of gastrointestinal mucus. Annu. Rev. Physiol. 57:565-583; 1995.
68. Perchellet, J.; Perchellet, E. M. Antioxidants and multistage carcinogenesis in mouse skin. Free Radic. Biol. Med. 7:377-408; 1989.
69. Oshima, M.; Dinchuk, J. E.; Kargman, S. L.; Oshima, H.; Hancock, B.; Kwong, E.; Trzaskos, J. M.; Evans, J. F.; Taketo, M. M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cycloxygenase 2 (COX-2). Cell 87(5):803-809; 1996.
70. Cejas, P.; Casado, E.; Belda-Iniesta, C.; de Castro, J.; Espinosa, E.; Redondo, A.; Sereno, M.; Garcia-Cabezas, M. A.; Vara, J. A.; Dominguez-Caceres, A.; Perona, R.; Gonzalez-Baron, M. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Cases Control 15(7):707-719; 2004.
71. Thun, M. J.; Henley, S. J.; Patrono, C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J. Natl. Cancer Inst. 20(4):252-266; 2002.
72. Sengupta, S.; Sellers, L. A.; Cindrova, T.; Skepper, J.; Gherardi, E.; Sasisekharan, R.; Fan, T. P. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis. Cancer Res. 1(23):8351-8359; 2003.